Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Jan 1995, 58-63, Vol 33, No. 1
Q An, J Liu, W O'Brien, G Radcliffe, D Buxton, S Popoff, W King, M Vera-Garcia, L Lu and J Shah
In order to study infections due to Chlamydia trachomatis, we have compared
semiquantitative PCR and Q beta replicase-amplified assays for detection of
this organism. The PCR assay was directed against the C. trachomatis 16S
rRNA gene. Quantitation was accomplished by adding known amounts of a
plasmid containing a truncated segment of the 16S rRNA gene target to
chlamydia-containing samples and then amplifying with a common primer set.
The Q beta replicase assay consisted of reversible target capture of C.
trachomatis 16S rRNA, which was followed by amplification of an RNA
detector probe in the presence of the enzyme Q beta replicase. In a
clinical matrix, the lower limit of detection of both the PCR and Q beta
replicase assays was five elementary bodies. The Q beta replicase and PCR
assays were quantitative over 10,000- and 1,000-fold ranges of organisms,
respectively. Analysis of the effects of endocervical matrix on
amplification was accomplished by examining 94 endocervical specimens by
each technique. Both assays detected five of six culture-confirmed
specimens as well as three culture-negative specimens. PCR inhibitors were
detected in 13 specimens. The Q beta replicase assay, in contrast, showed
no evidence of sample inhibition. The Q beta replicase and PCR assays
should allow quantitative investigation of infections due to C.
trachomatis. In addition, because it targets highly labile RNA, the Q beta
replicase assay may facilitate investigations into the role of active
persisting infection in culture-negative inflammatory conditions.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Comparison of characteristics of Q beta replicase-amplified assay with competitive PCR assay for Chlamydia trachomatis
Gene-Trak, Framingham, Massachusetts 01701.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|